The long-term follow-up of the Veteran Affairs Diabetes Trial is important for researchers and clinicians. For the former, this study supports the conclusion that dysglycaemia causes cardiovascular outcomes; for the latter, it shows that in high-risk individuals, the benefits of lowering glucose are modest and take a long time to emerge.
